Asia-Pacific Genomic Cancer Panel and Profiling Market: Focus on Application, End User, and Country - Analysis and Forecast, 2023-2033

November 2024 | | ID: A4C42779EFF3EN
BIS Research Inc.

Abstracts

Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request.

This report will be delivered in 1-5 working days.

Introduction to Asia-Pacific Genomic Cancer Panel and Profiling Market

The Asia-Pacific genomic cancer panel and profiling market is expected to reach $4.78 billion by 2033 from $1.56 billion in 2023. This growth is driven by advancements in genomic research and an increasing focus on precision medicine within the field of oncology.

Market Introduction

The Asia-Pacific (APAC) Genomic Cancer Panel and Profiling Market is experiencing significant growth, propelled by the rising incidence of cancer and the increasing adoption of personalized medicine across the region. Advances in genomic technologies and the expanding capabilities of next-generation sequencing (NGS) have enhanced the precision of cancer diagnostics and treatment strategies, catering specifically to individual genetic profiles. Governments and healthcare institutions are increasingly investing in healthcare infrastructure and genomic research, further stimulating market expansion. Moreover, collaborations between biotech firms are boosting access to advanced genomic tests. This market's growth is also supported by growing public awareness about the benefits of early cancer detection and targeted therapies, making the APAC region a vital player in the landscape of cancer genomics.

Market Segmentation

Segmentation 1: by Application

• Clinical
• Research

Segmentation 2: by End User

• Hospitals
• Clinical and Diagnostic Laboratories
• Research and Academic Institutes
• Other End Users

Segmentation 3: by Country

• China
• Japan
• India
• Australia
• South Korea
• Rest-of-Asia-Pacific

How can this report add value to an organization?

Product/Innovation Strategy: The Asia-Pacific genomic cancer panel and profiling market has been extensively segmented based on various categories, such as application, end user, and country. This can help readers get a clear overview of the segments accounting for the largest share and the ones that are well-positioned to grow in the coming years.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and regional presence.

Some of the prominent names in this market are:

• Burning Rock DX
• Genecast Biotechnology Co., Ltd

Contents

Executive Summary

1 MARKETS

1.1 Product Definition
1.2 Inclusion and Exclusion Criteria
  1.2.1 Inclusion Criteria
  1.2.2 Exclusion Criteria
1.3 Market Scope
  1.3.1 Scope of the Study
  1.3.2 Key Questions Answered in this Report
1.4 Research Methodology
  1.4.1 Genomic Cancer Panel and Profiling Market: Research Methodology
  1.4.2 Data Sources
  1.4.3 Market Estimation Model
  1.4.4 Criteria for Company Profiling
1.5 Market Overview
  1.5.1 Market Definition
  1.5.2 Market Footprint and Growth Potential
  1.5.3 Future Potential

2 BY REGION

2.1 Overview
2.2 Asia-Pacific
  2.2.1 Key Dynamics
  2.2.2 China
  2.2.3 Japan
  2.2.4 India
  2.2.5 Australia
  2.2.6 South Korea
  2.2.7 Rest-of-Asia-Pacific

3 COMPANY PROFILES

3.1 Overview
3.2 Burning Rock DX
  3.2.1 Company Overview
  3.2.2 Role of Burning Rock DX in the Genomic Cancer Panel and Profiling Market
  3.2.3 Business Strategies
  3.2.4 Analyst Perspective
3.3 Genecast Biotechnology Co., Ltd
  3.3.1 Company Overview
  3.3.2 Role of Genecast Biotechnology Co., Ltd in the Genomic Cancer Panel and Profiling Market
  3.3.3 Analyst Perspective

List Of Figures

LIST OF FIGURES

Figure 1: Asia-Pacific Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
Figure 2: Asia-Pacific Genomic Cancer Panel and Profiling Market (by Application), % Share, 2022 and 2033
Figure 3: Asia-Pacific Genomic Cancer Panel and Profiling Market (by End User), % Share 2022 and 2033
Figure 4: Genomic Cancer Panel and Profiling Market Snapshot (by Region), $Billion, 2022
Figure 5: Genomic Cancer Panel and Profiling Market Segmentation
Figure 6: Genomic Cancer Panel and Profiling Market: Research Methodology
Figure 7: Primary Research Methodology
Figure 8: Bottom-Up Approach (Segment-Wise Analysis)
Figure 9: Top-Down Approach (Segment-Wise Analysis)
Figure 10: Genomic Cancer Panel and Profiling Workflow, End User Perspective
Figure 11: Genomic Cancer Panel and Profiling Workflow, Laboratory Technician Perspective
Figure 12: Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
Figure 13: Genomic Cancer Panel and Profiling Market Snapshot (by Region), $Billion, 2022
Figure 14: Asia-Pacific Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
Figure 15: Asia-Pacific Genomic Cancer Panel and Profiling Market (by Application), $Million, 2022-2033
Figure 16: Asia-Pacific Genomic Cancer Panel and Profiling Market (by End User), $Million, 2022-2033
Figure 17: Asia-Pacific Genomic Cancer Panel and Profiling Market (by Country), $Billion, 2022-2033
Figure 18: China Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
Figure 19: Japan Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
Figure 20: India Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
Figure 21: Australia Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
Figure 22: South Korea Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
Figure 23: Rest-of-Asia-Pacific Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
Figure 24: Genomic Cancer Panel and Profiling Market, Total Number of Companies Profiled
Figure 25: Burning Rock DX: Product Portfolio
Figure 26: Genecast Biotechnology Co., Ltd: Product Portfolio

List Of Tables

LIST OF TABLES

Table 1: Technological Trends in the Genomic Cancer Panel and Profiling Market
Table 2: Asia-Pacific Genomic Cancer Panel and Profiling Market, Impact Analysis